Delivery Order SPE2DB20D2104-SPE2DB23FR07P
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Medical Supply Chain for the delivery of Stelara 90 mg/ml syringes. The Firm Fixed Price delivery order, valued at $12,715.97, has an ultimate completion date of March 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order worth $8,293.57 for the supply of Stelara 90 mg/ml syringes. The contract has an ultimate completion date of February 1, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DX15D2012|SPE2DX24F7TD2) with a ceiling value of $27,290.51. The contract is for the supply of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The award has an ultimate completion date of December 5, 2023 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Stelara 90 mg/ml syringes. The $11,265.74 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) with a performance period through May 18, 2023. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $75,218.53 Firm Fixed Price Delivery Order for the supply of STELARA 90 MG/ML syringes. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is a major customer for Amerisourcebergen's federal contracting activities. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $8,861.95 for the supply of STELARA 90 MG/ML SYRINGEML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 20, 2022. The contract is a firm fixed-price delivery order, and there was no set-aside designation used. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,366.01 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes and has a completion date of June 21, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,337.92 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringe, a specialty medication. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,987.59 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the...
- This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $29,168.89 and is a firm fixed-price delivery order with an ultimate completion date of January 30, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FR07PDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $15,397.08 for the supply of STELARA 90 MG/ML SYRINGEML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 15, 2022. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order is likely part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 11/14/22 |